Cardiovascular Diseases Research in Rhode Island
Cardiovascular Diseases Research (93.837) awarded $93.3 million to recipients in Rhode Island in 114 grants from fiscal 2021 to 2025, 0.6% of the program's national total. Rhode Island Hospital received the most, $35.9 million.
- Awarded in Rhode Island$93.3 million
- Awards114
- Share of the program0.6%
- Rank among states29th of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 43 | $17.3 million |
| FY 2022 | 47 | $18.9 million |
| FY 2023 | 55 | $18.5 million |
| FY 2024 | 48 | $18.8 million |
| FY 2025 | 47 | $19.8 million |
Recipients in Rhode Island
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Rhode Island Hospital | Nonprofits | 28 | $35.9 million |
| Brown University | Colleges and universities | 25 | $29.2 million |
| The Miriam Hospital | Nonprofits | 13 | $14.5 million |
| Ocean State Research Institute Inc | Nonprofits | 5 | $6.4 million |
| University of Rhode Island | Nonprofits | 5 | $3.4 million |
| Kent County Memorial Hospital | Nonprofits | 1 | $2.8 million |
| Gordon Research Conferences | Nonprofits | 34 | $598,375 |
| Emma Pendleton Bradley Hospital | Nonprofits | 2 | $518,982 |
| Women & Infants Hospital of Rhode Island | Nonprofits | 1 | $507,321 |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 82 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Rhode Island?
$93.3 million from fiscal 2021 to 2025, across 114 awards. Rhode Island ranks 29th of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Rhode Island?
The largest recipient is Rhode Island Hospital, with $35.9 million in 28 awards. Next are Brown University and The Miriam Hospital.
Can organizations in Rhode Island apply now?
Yes, 82 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Rhode Island
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Children's Health Insurance Program
- Temporary Assistance for Needy Families
- Federal Transit Formula Grants
- Title I Grants to Local Educational Agencies
- National School Lunch Program
- Special Education Grants to States